Evidence map›Paper›PMID 40193665›Full record

ArticleMedicine2025

Remitting seronegative symmetrical synovitis with pitting edema syndrome with two different underlying malignancies: A case report.

Samar Alharbi

Abstract readCase Reports
In one paragraph

Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Samar AlharbiDepartment of Medicine, College of Medicine, Taibah University, King Salman Medical City, Medina, Saudi Arabia.ORCID 0000-0002-0904-0514

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleRemitting seronegative symmetric synovitis with pitting edema is a rare, benign disorder symmetrically affecting the peripheral joints. It begins with acute-onset pitting edema on the dorsum of the hands and feet, and primarily affects elderly men and has a favorable response to low-dose steroids. It may also be a paraneoplastic symptom of an underlying hidden cancer; hence, thorough clinical evaluation is required. PATIENT CONCERNS: A 58-year-old woman who presented with acute-onset polyarthritis and pitting edema affecting both hands and feet. Based on clinical and laboratory findings, remitting seronegative symmetric synovitis with pitting edema was diagnosed. A thorough clinical investigation led to a diagnosis of papillary thyroid carcinoma and adenocarcinoma of unknown origin. DIAGNOSES: Based on clinical and laboratory findings, remitting seronegative symmetric synovitis with pitting edema was diagnosed. A thorough clinical investigation led to a diagnosis of papillary thyroid carcinoma and adenocarcinoma of unknown origin.

interventionsThe patient initially received prednisolone; when she faced difficulty in maintaining remission at a dose of <12.5 mg, hydroxychloroquine was added. Subsequently, the corticosteroid dose was tapered successfully without further arthritis flares. She also received palliative chemotherapy for an unknown primary. OUTCOMES: Five rounds of chemotherapy successfully reduced the size of bilateral inguinal lymphadenopathy and garnered resolution of the small bilateral external iliac lymph nodes. Both corticosteroid and hydroxychloroquine discontinued. The patient remained stable and cancer-free at the 9-month follow-up. LESSONS: Physicians should be knowledgeable about the distinct signs and symptoms of remitting seronegative symmetric synovitis with pitting edema and investigate patients suspected of having the syndrome for hidden cancers.

Indexed as

AdenocarcinomaCarcinoma, PapillaryEdemaNeoplasms, Unknown PrimaryParaneoplastic SyndromesSynovitisThyroid Cancer, PapillaryThyroid NeoplasmsFemaleHumansMiddle AgedSyndromearthritiscorticosteroidsmalignancypitting edemaRS3PEseronegative

Identifiers

PMID40193665
PMCPMC11977687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.